Ajanta Pharma

AJANTPHARM25 Apr 2024
Pharmaceuticals
+8.60 (+0.40%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Ajanta Pharma
Ajanta Pharma
Pharmaceuticals
AJANTPHARM25 Apr 2024
+8.60 (+0.40%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Ajanta Pharma - Share Price & Details

Lowest Today
2127.1
Highest Today
2188.7
Today’s Open
2188.7
Prev. Close
2131.4
52 Week High
2355.05
52 Week Low
1240.55
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
65.86%
Upper Circuit
Lower Circuit
P/E TTM
35.23
P/B Ratio
8.00
Traded Value(Cr)
0.00
EPS TTM
60.5
Book value
Dividend
0.33%

Price Performance

2.49 %
1 Wk
-3.96 %
1 M
-2.93 %
3 M
65.86 %
1 Y
-1.04 %
YTD

Traded Volume Movement

Technical Details

Support 3
2110
Support 2
2118
Support 1
2129
Pivot Point :
2137
Resistance 1
2148
Resistance 2
2156
Resistance 3
2168

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Ajanta Pharma Ltd
₹2,140.00(+8.60/0.40%)
2,140.00+8.6026,837.8865.8635.238.00
Astrazeneca Pharma India Ltd
₹5,304.10(+34.80/0.66%)
5,304.10+34.8013,173.2567.2782.5920.11
Cipla Ltd
₹1,390.80(-8.00/-0.57%)
1,390.80-8.00112,938.4154.9134.344.36
Bliss GVS Pharma Ltd
₹116.00(+0.35/0.30%)
116.00+0.351,210.7548.8417.741.24
Abbott India Ltd
₹25,447.50(-14.70/-0.06%)
25,447.50-14.7054,107.1813.0347.2317.40
Amrutanjan Health Care Ltd
₹679.70(-0.05/-0.01%)
679.70-0.051,965.2012.7144.667.50

About Ajanta Pharma Ltd

Ajanta Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 26837.88 crores. It has reported a sales of Rs. 1085.29 crores and a net profit of Rs. 220.15 crores for the quarter ended December 2018. The company management includes Mannalal B Agrawal, Mannalal B Agrawal,Madhusudan B Agrawal,Yogesh Agrawal,Chandrakanth M Khetan,Gaurang Shah,Rajesh M Agrawal,K H Viswanathan,Prabhakar Dalal,Anjana Grewal (Ajanta Pharma Ltd) among others.
Chairman
Mannalal B Agrawal
Registered office
Ajanta House,Charkop Kandivli (W),Mumbai,Maharashtra,400067
FAX :91-22-66061200/1300
Background
Incorporation Year1979
Face Value₹2
Market Lot1

Latest News

📢 Sensex plunges 213 points at the open; Nifty below 22,350
📈 Amid weak global cues, domestic benchmark indices started gap-down on April 25.
📢 At 9:16 AM, the Sensex tanked 212.95 points or 0.29% at 73,639.99, and the Nifty plunged 63.20 points or 0.28% at 22,339.20.
📊 Kotak Mahindra Bank (⬇️9.27%), LTIM (⬇️2.13%) and HUL (⬇️0.97%) appeared as the top losers on the Nifty 50 at the Open.
25 Apr 2024 | 09:24 AM
📢 Sensex plunges 213 points at the open; Nifty below 22,350
📈 Amid weak global cues, domestic benchmark indices started gap-down on April 25.
📢 At 9:16 AM, the Sensex tanked 212.95 points or 0.29% at 73,639.99, and the Nifty plunged 63.20 points or 0.28% at 22,339.20.
📊 Kotak Mahindra Bank (⬇️9.27%), LTIM (⬇️2.13%) and HUL (⬇️0.97%) appeared as the top losers on the Nifty 50 at the Open.
25 Apr 2024 | 09:24 AM
Meta Q1 Results: Facebook parent more than doubles profit to $12.37 billion
Meta Q1 Results: Facebook and Instagram parent company Meta said Wednesday its Q1 profit more than doubled, boosted by higher advertising revenue and a 6% increase on the average price of ads on its platforms. But its shares dropped sharply in after-hours trading following lukewarm revenue guidance.Meta Platforms Inc. earned $12.37 billion, or $4.71 per share, in the January-March period.
25 Apr 2024 | 09:59 AM
IEL Q4 results: profit at  ₹0.14Cr, Revenue increased by 5898.75% YoY
IEL Q4 Results: IEL announced their Q4 results on 22 Apr, 2024, showcasing a remarkable performance. The company's revenue surged by an impressive 5898.75% year-over-year, reaching a significant high. The profit for the quarter stood at  ₹0.14 crore, marking a substantial improvement from the loss of  ₹0.04 crore reported in the same period last fiscal year.
25 Apr 2024 | 09:58 AM
Rallis India Q4 Results: loss falls by 69.62% YOY
Rallis India Q4 Results Live : Rallis India declared their Q4 results on 22 Apr, 2024. The topline decreased by 16.57% & the loss decreased by 69.62% YoY. Compared to the previous quarter, the revenue declined by 27.09% and the loss increased by 187.5%.The Selling, general & administrative expenses declined by 0% q-o-q & increased by 8.66% Y-o-Y. The operating income was down by 184.38% q-o-q.
25 Apr 2024 | 09:52 AM

How to buy Ajanta Pharma shares on nse?

To buy Ajanta Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Ajanta Pharma share price today?

The Ajanta Pharma shares price on nse is Rs.2140 today.

What is the market cap of Ajanta Pharma shares on BSE ?

The company has a market capitalization of Rs.26837.88Cr

What is the PE & PB ratio of Ajanta Pharma shares ?

PE is 35.23 and PB is 8

What is the 52 Week High and Low of Ajanta Pharma shares?

Ajanta Pharma stock price high: Rs.2355.05 Ajanta Pharma stock price low: Rs.1240.55

How can I purchase Ajanta Pharma stock with Motilal Oswal?

You can easily purchase Ajanta Pharma stock by signing up with ace broker Motilal Oswal and opening a demat account. Then you will have to open a trading account linked with your demat account and this helps you to conduct transactions (buy and sell stock). After this, you can buy Ajanta Pharma stock on the stock exchange through Motilal Oswal. 

Is Ajanta Pharma a good investment?

According to price and trend analysis, experts say that Ajanta Pharma is a semi-strong stock investment. This means that the stock may rise to a certain extent in the short run. Depending on investment needs and goals, you can invest accordingly. 

Is Ajanta Pharma debt free?

In September 2022, Ajanta Pharma held a debt of Rs. 284.8 million. This was higher by more than Rs. 200 million from the previous year.

What is the dividend yield of Ajanta Pharma?

The dividend yield of Ajanta Pharma is 0.82% (March 2022).